• No results found

B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma

N/A
N/A
Protected

Academic year: 2020

Share "B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma"

Copied!
13
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1. Treatment schema. Cytoxan indicates cyclophosphamide. *Patients may receive therapy during manufacturing to maintain disease control
Table 1. Subject characteristics
Figure 2. Clinical outcomes. (itoneal lymph nodes (LN), known to contain myeloma by prior biopsy, that decreased in size by more than 50% and became FDG-negative on PET/CT but did not disappear
Figure 3. CART-BCMA expansion and persistence. (A–C) CART-BCMA cell levels over time in peripheral blood for each cohort are depicted, as measured by quantitative PCR for CAR sequence
+4

References

Related documents

The RTO NATO (2005) review suggests that the Input, Processes, Outputs (IPO) concept used by the majority of the models, analyzes critical characteristics of team effectiveness

19.2.5 It shall be the responsibility of the successful BA/SI to maintain the agreed Quality of Service, even during the period when the notice for surrender/termination of agreement

Although the exact list of designated off-ramps will differ between distributed generation and utility-scale projects, common reasons for early termination of a utility-scale PPA may

AASB134.16A(c) The notes to the condensed consolidated financial statements shall disclose, if not disclosed elsewhere in the half-year financial report, the nature and amount

In this section we prove the classification theorem, in a more general case; we prove that there are 999 non- isomorphic, connected Dynkin diagrams associated with

To gain insight to the mechanism for improved performance in Cd-containing NBG PSCs, carrier diffusion length of electrons and holes in the NBG perovskites with and without Cd 2 +